# Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease

> **NCT01082965** · NA · TERMINATED · sponsor: **Pfizer** · enrollment: 18 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01082965
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** The study was terminated because of slow enrollment. The decision to terminate the trial was not based on any safety or efficacy concerns.
- **Last updated:** 2013-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082965, "Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01082965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*